ATE473000T1 - Dichloroazetat zusammen mit einem inotropen medikament zur cardioprotektion - Google Patents

Dichloroazetat zusammen mit einem inotropen medikament zur cardioprotektion

Info

Publication number
ATE473000T1
ATE473000T1 AT04702767T AT04702767T ATE473000T1 AT E473000 T1 ATE473000 T1 AT E473000T1 AT 04702767 T AT04702767 T AT 04702767T AT 04702767 T AT04702767 T AT 04702767T AT E473000 T1 ATE473000 T1 AT E473000T1
Authority
AT
Austria
Prior art keywords
dichloroacetate
cardioprotection
along
inotropic drug
inotropic
Prior art date
Application number
AT04702767T
Other languages
English (en)
Inventor
Gary Lopaschuk
Ruth Collins-Nakai
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE473000T1 publication Critical patent/ATE473000T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04702767T 2004-01-16 2004-01-16 Dichloroazetat zusammen mit einem inotropen medikament zur cardioprotektion ATE473000T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2004/000662 WO2005077353A1 (en) 2004-01-16 2004-01-16 Dichloroacetate in combination with an inotrope for cardioprotection

Publications (1)

Publication Number Publication Date
ATE473000T1 true ATE473000T1 (de) 2010-07-15

Family

ID=34746643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04702767T ATE473000T1 (de) 2004-01-16 2004-01-16 Dichloroazetat zusammen mit einem inotropen medikament zur cardioprotektion

Country Status (8)

Country Link
EP (1) EP1708692B1 (de)
JP (1) JP2007517853A (de)
CN (1) CN1925851A (de)
AT (1) ATE473000T1 (de)
AU (1) AU2004315552A1 (de)
CA (1) CA2489853A1 (de)
DE (1) DE602004028046D1 (de)
WO (1) WO2005077353A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060194878A1 (en) * 2002-10-07 2006-08-31 Lopaschuk Gary D Methods of cardioprotection using dichloroacetate in combination with an inotrope
RU2644305C1 (ru) * 2017-01-20 2018-02-08 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации, ФГБОУ ВО КубГМУ Минздрава России Способ снижения гепатоцитолиза в условиях частичной сосудистой изоляции печени в эксперименте
CN111773204B (zh) * 2019-04-03 2023-01-24 上海市浦东新区浦南医院 二氯乙酸钠在制备治疗血管性痴呆药物中的用途
LT6874B (lt) 2020-04-17 2021-12-10 Lietuvos sveikatos mokslų universitetas Valpro rūgšties ir dichloroacetato druskų derinio taikymas vėžio gydymui
LT7129B (lt) 2023-08-22 2025-03-25 Lietuvos sveikatos mokslų universitetas Natrio dichloroacetato ir valpro rūgšties druskų derinys, skirtas virusinėms ir bakterinėms infekcijoms, ir uždegiminėms ligoms gydyti

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410320D0 (en) * 1994-05-24 1994-07-13 Fisons Corp Novel therapeutic method
EP0786993B1 (de) * 1994-10-17 2002-06-05 Peter W. Stacpoole Carbonat/bicarbonat gepufferte dichloressigsäure enthaltende mittel und deren verwendung in der behandlung von metabolischen und kardiovaskulären erkrankungen
US6076528A (en) * 1996-05-09 2000-06-20 Cypros Pharmaceutical Corp. Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass grafting surgery
CA2305183C (en) * 1997-10-03 2008-09-23 The Governors Of The University Of Alberta Postsurgical treatment with dichloroacetate
JP2005533796A (ja) * 2002-06-20 2005-11-10 ザ・ガバナーズ・オブ・ザ・ユニバーシティ・オブ・アルバータ 心臓保護薬または血行動態薬との併用におけるジクロロ酢酸塩
US6693133B1 (en) * 2002-10-07 2004-02-17 University Of Alberta Methods of cardioprotection using dichloroacetate in combination with an inotrope

Also Published As

Publication number Publication date
AU2004315552A1 (en) 2005-08-25
DE602004028046D1 (de) 2010-08-19
CA2489853A1 (en) 2005-07-16
JP2007517853A (ja) 2007-07-05
WO2005077353A8 (en) 2005-12-15
EP1708692A1 (de) 2006-10-11
WO2005077353A1 (en) 2005-08-25
CN1925851A (zh) 2007-03-07
EP1708692B1 (de) 2010-07-07

Similar Documents

Publication Publication Date Title
EP1758597A4 (de) Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz
GB2465677B (en) Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
IL244803A0 (en) Human anti-beta7 antibodies and their use
EP2468776A3 (de) Antikörper gegen Robo4 und Anwendungen davon
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
ZA200701656B (en) Humanized anti-cment antagonists
WO2007044026A3 (en) Compositions comprising modified collagen and uses therefore
WO2008140493A3 (en) Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
ATE526987T1 (de) Dr5-antikörper und deren verwendung
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
GT200500230A (es) Nuevas composiciones farmacèuticas para el tratamiento de trastornos hiperproliferativos
IL191824A0 (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling
WO2012047587A3 (en) Mdm2 inhibitors for treatment of ocular conditions
CY1117603T1 (el) Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
CL2007001710A1 (es) Compuestos derivados de amino-pirazolopiridina sustituidos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como tumores, artritis reumatoide, enfermedades de crecimiento vascular desregulado, entre otras.
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
CL2008000021A1 (es) Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer.
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MY135829A (en) Analeptic and drug combinations
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs
MX337358B (es) Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos.
DE602005027400D1 (de) Il-22 zur behandlung von fettleibigkeit, diabetes, hyperlipidämie, hyperglykämie und insulinresistenz
WO2007030944A3 (en) Methods of cardioprotection using dichloroacetate in combination with an inotrope

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties